Ultragenyx to lay off 20% of workers, reduce real estate footprint as it cuts R&D
Key points
- Ultragenyx will lay off 20% of its workers
- It will also reduce its real estate footprint
- It is cutting research and development
The Business Journals reports that biopharmaceutical company Ultragenyx will lay off 20% of its workers, reduce its real estate footprint, and cut research and development.
Original report: The Business Journals ↗AI-assisted brief; may contain inaccuracies. Rely on the original reports and official documents.
